- Home
- MNDO vs NNVC Comparison
MNDO vs NNVC Comparison
Compare MNDO & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- NNVC
- Stock Information
- Founded
- MNDO 1995
- NNVC 2005
- Country
- MNDO Israel
- NNVC United States
- Employees
- MNDO N/A
- NNVC N/A
- Industry
- MNDO EDP Services
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- NNVC Health Care
- Exchange
- MNDO Nasdaq
- NNVC Nasdaq
- Market Cap
- MNDO 26.5M
- NNVC 22.5M
- IPO Year
- MNDO 2000
- NNVC N/A
- Fundamental
- Price
- MNDO $1.33
- NNVC $1.58
- Analyst Decision
- MNDO
- NNVC
- Analyst Count
- MNDO 0
- NNVC 0
- Target Price
- MNDO N/A
- NNVC N/A
- AVG Volume (30 Days)
- MNDO 30.3K
- NNVC 306.6K
- Earning Date
- MNDO 08-19-2025
- NNVC 09-26-2025
- Dividend Yield
- MNDO 16.54%
- NNVC N/A
- EPS Growth
- MNDO N/A
- NNVC N/A
- EPS
- MNDO 0.17
- NNVC N/A
- Revenue
- MNDO $20,677,000.00
- NNVC N/A
- Revenue This Year
- MNDO N/A
- NNVC N/A
- Revenue Next Year
- MNDO N/A
- NNVC N/A
- P/E Ratio
- MNDO $7.82
- NNVC N/A
- Revenue Growth
- MNDO N/A
- NNVC N/A
- 52 Week Low
- MNDO $1.29
- NNVC $0.94
- 52 Week High
- MNDO $2.13
- NNVC $2.34
- Technical
- Relative Strength Index (RSI)
- MNDO 37.92
- NNVC 50.16
- Support Level
- MNDO $1.29
- NNVC $1.55
- Resistance Level
- MNDO $1.35
- NNVC $1.60
- Average True Range (ATR)
- MNDO 0.04
- NNVC 0.06
- MACD
- MNDO -0.01
- NNVC -0.02
- Stochastic Oscillator
- MNDO 19.05
- NNVC 12.50
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.